Acceleron
AcquiredCambridge, United States · Founded 2003 · $10.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 201–500
- Founded
- 2003
- Business Model
- B2B
- Total Funding
- $10.0M
- Last Round
- $10.0M Series G+Jun 2010
- Rounds
- 1
- Acquired by
- Merck & Co.Sep 2021
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.
About
Acceleron Pharma, Inc. was an American clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on discovering and developing protein therapeutics that regulate the TGF-beta superfamily of proteins involved in cell and tissue growth and repair. Its pipeline included luspatercept for anemia and sotatercept for pulmonary arterial hypertension, developed in partnership with Celgene. Acceleron went public on Nasdaq (XLRN) in 2013 and was acquired by Merck & Co. for $11.5 billion in November 2021, becoming a wholly owned subsidiary.
Summary
Acceleron is a Biotech company based in Cambridge, United States, founded in 2003. It has raised $10.0M in total across 1 round, most recently a $10.0M Series G+ round in Jun 2010. Investors include Bessemer Venture Partners.
Funding & Exit History
Sep 2021
Sign up to see all 2 events
Funding: Series G+. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/acceleron"><img src="https://indexed.vc/api/badge/company/acceleron" alt="Acceleron on Indexed.vc" width="260" height="76" /></a>